Company intelligence / Profile preview

GH3 International

Markham, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

GH3 International is a health and wellness company specializing in anti-aging products based on the Gerovital H3 formula originally developed by Dr. Ana Aslan. The company focuses on the distribution of procaine-based supplements and skincare treatments designed to support cellular health and longevity. Their flagship product, GH3, is marketed for its potential to improve cognitive function, mood, and physical vitality in aging populations. GH3 International operates primarily through a direct-to-consumer and distributor network, catering to the global longevity and nutraceutical markets.

Therapeutic areas: DermatologyNeurologyOther
Modalities: Small moleculePeptides
Industry: Food & Nutrition

Beyond the preview

Go deeper on GH3 International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GH3 International.

Explore the full profile